Market Sectors

The general public has become more focused on health and healthcare issues than ever before. That has put additional emphasis on the role of marketing communications and technology, because effective communication has become vital to the success of any new pharmaceutical or biochem product, diagnostic tool or digital service offering.

Results International has a dedicated team of seven professionals who focus on the growing healthcare services market, including communications, consultancy and medical technology. We have completed 16 transactions in the healthcare sector and are managing a considerable number of active transactions as well.

We have advised both marketing services groups and independent businesses, located around the globe, that are looking to make the most of the burgeoning public interest in healthcare. 

Contract Research Organisations and other elements of healthcare research have become increasingly attractive to marketing communications companies looking to increase their healthcare business.

We have worked with buyers who are keen to leverage these links in order to boost their own standing within the sector.

Results International has worked with companies involved in market access training and all other aspects of value communications. New products may have a lot to offer, but it's vital that value messages be effectively communicated to the influencers behind funding and reimbursement decisions.

Technology, particularly in the US at present, is in high demand at present from a broad range of buyers keen to streamline the healthcare communications process. Whether for diagnostic trials or patient communications, technology that improves accuracy and efficiency is highly sought.

Results International has a long and extremely successful track record in working with healthcare PR businesses. It's a highly specialist area of marketing communications that is unlike traditional PR in several aspects - not least the restrictions in communication faced by practitioners when dealing with the public.

As a result, successful healthcare PR is at a premium and many buyer groups are looking to build their presence in this area - everything from drug safety trials, pre-launch communications and health policy impacts to media relations, stakeholder and crisis management and public affairs.
 

This is a highly specific space and the global market in medical education varies wildly from one location to another - for example communicating with medical professionals in the US is vastly different from doing so in the UK. Results' knowledge and experience of the global marketing communications and technology environment for medical education is second to none, particularly the buyer landscape for those businesses in the industry looking for new partners or investors.
 

Results International are very active in the market access sector, advising businesses involved in payer research and market access media. Evidentiary support and communications strategy can make or break how a new drug gets to market and demand for these services has never been higher.

There are plenty of buyers keen to acquire the best expertise in market access - and we know them all.  We can work with either side to ensure transactions make sense for everyone involved.

Pricing Submissions and Health Technology Assessments (HTAs) require rigorous economic analytics to be undertaken to ensure cost-benefit. This has led to massive growth in businesses able to provide these in-depth evaluations and has led to increased interest from buyers in  every area of the healthcare market.

Results International can help to bring these businesses to the next level with the right investment partner and ensure their continued success in an increasingly competitive market.

The digital world has become an integral component of healthcare provision and Results works with companies that specialise in this area.

Services such as online PR and social media, whether communicating with patients or other healthcare businesses, are growing increasingly prevalent. Similarly, website build, SEO and other creative digital disciplines have come to the fore as pharmaceutical organisations look for new ways to get their message across to a sophisticated, internet-savvy audience.

The pharmaceuticals sector is keen to engineer better and more reliable trials, and this has placed additional pressure on providers of relevant new technology, innovative diagnostic tools and patient communications. They need to ensure their voices are being heard.

We work with those businesses as well as with CROs and other industry buyers keen to demonstrate the effectiveness of successful clinical trials. In the current market, communicating the evidence has become just as important as acquiring it in the first place.